Search

Your search keyword '"Kung, Andrew L."' showing total 1,393 results

Search Constraints

Start Over You searched for: Author "Kung, Andrew L." Remove constraint Author: "Kung, Andrew L."
1,393 results on '"Kung, Andrew L."'

Search Results

2. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm

3. Clonal evolution during metastatic spread in high-risk neuroblastoma

4. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients

6. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

7. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation

8. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation

9. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors

10. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

11. Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation

12. Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy

13. Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients

14. Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation

15. Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy

17. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

18. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

20. Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy

21. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

22. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway

23. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

24. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma

25. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

27. BET bromodomain proteins regulate enhancer function during adipogenesis

29. Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy

30. Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

33. Clonal hematopoiesis in survivors of childhood cancer

34. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

35. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

36. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

37. A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

43. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.

44. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

47. Abstract 2149: A whole genome sequencing classifier of homologous recombination deficiency

48. Abstract 3142: Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

49. Supplementary Table S1.4 from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

50. Data from Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma

Catalog

Books, media, physical & digital resources